Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals
Authors
Keywords
-
Journal
CHEMICAL & PHARMACEUTICAL BULLETIN
Volume 71, Issue 5, Pages 360-367
Publisher
Pharmaceutical Society of Japan
Online
2023-05-01
DOI
10.1248/cpb.c23-00035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molnupiravir: First Approval
- (2022) Yahiya Y. Syed DRUGS
- Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CLpro Main Protease
- (2022) Barbara Herlah et al. Pharmaceuticals
- Computational and Crystallographic Analysis of Binding Structures of Inhibitory Compounds for HIV-1 RNase H Activity
- (2022) Huiyan Lu et al. Journal of Chemical Information and Modeling
- Improved Protein–Ligand Binding Affinity Prediction with Structure-Based Deep Fusion Inference
- (2021) Derek Jones et al. Journal of Chemical Information and Modeling
- Analysis of Binding Modes of Antigen–Antibody Complexes by Molecular Mechanics Calculation
- (2021) Liang Qu et al. Journal of Chemical Information and Modeling
- Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening
- (2021) Aayush Gupta et al. Journal of Chemical Information and Modeling
- AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
- (2021) Jerome Eberhardt et al. Journal of Chemical Information and Modeling
- Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro
- (2021) Shani Zev et al. Journal of Chemical Information and Modeling
- 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
- (2021) Sho Konno et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
- (2021) Chun-Hui Zhang et al. ACS Medicinal Chemistry Letters
- Identification of the Inhibitory Compounds for Metallo-β-lactamases and Structural Analysis of the Binding Modes
- (2021) Taichi Kamo et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study
- (2021) Souvik Banerjee et al. Journal of Chemical Information and Modeling
- Secondary Structure and Conformational Stability of the Antigen Residues Making Contact with Antibodies
- (2021) Xinyue Qiao et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
- (2021) Abhik Kumar Ray et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
- (2020) Junmei Wang Journal of Chemical Information and Modeling
- Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations
- (2020) Hugo Guterres et al. Journal of Chemical Information and Modeling
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- High-Throughput Screening: today’s biochemical and cell-based approaches
- (2020) Vincent Blay et al. DRUG DISCOVERY TODAY
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease
- (2020) Akshita Gupta et al. ACS Omega
- Computational Study on the Assembly of Amyloid β-Peptides in the Hydrophobic Environment
- (2019) Liang Qu et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- Recent advances in virtual screening for drug discovery
- (2015) Chung-Hang Leung et al. METHODS
- Hierarchical virtual screening approaches in small molecule drug discovery
- (2015) Ashutosh Kumar et al. METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now